Welcome to Inner Mongolia Zhonghui Pharmaceutical Co., Ltd., strategically nestled in the Biomedical Development Zone of Kailu County, Tongliao City, Inner Mongolia. Our company, established in 2021, is a proud venture initiated and constructed by Hebei Huada Zhongke Medical Technology Co., Ltd., leveraging the advantageous business environment and rich raw material resources of Kailu.

Strategic Investment and Robust Infrastructure:
With a significant investment of 1.3 billion yuan, Zhonghui Pharmaceutical boasts a sprawling 30-acre facility dedicated to the production of anti-infective Active Pharmaceutical Ingredients (APIs). Our infrastructure is designed to meet the highest industry standards and contribute to the global pharmaceutical landscape.

Phased Development for Excellence:
Zhonghui Pharmaceutical’s development unfolds in two strategic phases. The first phase, backed by an investment of 500 million yuan, reached a milestone in August 2022. This phase focuses on the annual production of 2,000 tons of doxycycline hyclate, currently undergoing trial production.

The second phase, with an additional investment of 800 million yuan, is set to commence operations in May 2024. This phase aims to produce an annual output of 4,000 tons of oxytetracycline base, showcasing our commitment to expanding and diversifying our pharmaceutical contributions.

Visionary Mission:
Our overarching dream at Zhonghui Pharmaceutical is to establish a “modern, standardized, and scientific” world-class pharmaceutical company. We envision contributing significantly to advancements in pharmaceuticals, setting new benchmarks in quality, innovation, and sustainability.

Thank you for choosing Zhonghui Pharmaceutical as your trusted partner in pharmaceutical excellence. Together, let’s shape a healthier and more resilient future.